Related references
Note: Only part of the references are listed.Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Thrombotic risk in COVID-19: a case series and case-control study
Simon M. Stoneham et al.
CLINICAL MEDICINE (2020)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Incidence of venous thromboembolism in hospitalized patients with COVID-19
Saskia Middeldorp et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study Rationale and Design
Derek C. Angus et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Pulmonary intravascular coagulopathy in COVID-19 pneumonia reply
Dennis McGonagle et al.
LANCET RHEUMATOLOGY (2020)
Share Paper
